| Literature DB >> 26107256 |
Pamela E Jeter1, Steffany Haaz Moonaz2, Ava K Bittner3, Gislin Dagnelie4.
Abstract
OBJECTIVE: Persons with visual impairment (VI) are at greater risk for falls due to irreparable damage to visual sensory input contributing to balance. Targeted training may significantly improve postural stability by strengthening the remaining sensory systems. Here, we evaluate the Ashtanga-based Yoga Therapy (AYT) program as a multi-sensory behavioral intervention to develop postural stability in VI.Entities:
Mesh:
Year: 2015 PMID: 26107256 PMCID: PMC4479589 DOI: 10.1371/journal.pone.0129646
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Participant Flow Chart.
Ashtanga-based Yoga Therapy Sequence.
| Time | Order | Poses |
|---|---|---|
| 15 mins | 1 |
|
| 2 |
| |
| 3 | Transition to Table Pose | |
| 4 |
| |
| 5 | From Table to | |
| 6 | From Table to Downward-facing Dog. Move from Downward-facing dog to standing. | |
| 30 mins | 7 |
|
| 8 |
| |
| 9 |
| |
| 10 |
| |
| 11 |
| |
| 12 |
| |
| 13 |
| |
| 14 |
| |
|
| ||
| 15 |
| |
| 16 |
| |
| 17 |
| |
| 18 |
| |
| 19 |
| |
| 20 |
| |
| 21 |
| |
| 22 |
| |
| 15 mins | 23 |
|
| 24 |
| |
| 25 |
|
Fig 2Use of the Wii Balance Board for the mCTSIB protocol.
A) Subject standing on foam, B) Wii Balance Board. Four sensors are located in each corner. Center of Pressure is derived as an x and y coordinate measured over time.
Stability Index Formula and Description.
| Stability Indices | Determines the relative contribution of the… |
|---|---|
|
| Visual system on a firm surface (baseline) |
|
| Visual system on an unstable or Foam surface, i.e. the somatosensory system is disrupted |
|
| Somatosensory system with Eyes Open. |
|
| Somatosensory system with Eyes Closed, i.e. vision is disrupted |
|
| Vestibular system while Vision and Somatosensory systems are disrupted (most challenging) |
Note: Under ideal conditions, all sensory systems work in concert therefore some redundancy exists. COP in conditions of increasing difficulty are measured. To determine the Stability Index, the visual and/or somatosensory systems are experimentally disrupted to derive the relative contribution of each system, however, the vestibular system is never experimentally disrupted. This protocol has been validated and has been used consistently for clinical assessment.
Demographic and Visual History.
| Group Assignment | Age | Gender | Race | Diagnosis | OS | OD | Visual Field |
|---|---|---|---|---|---|---|---|
| Yoga | 44 | M | Caucasian | Retinitis Pigmentosa | 20/30 | 20/30 | <10 |
| Yoga | 64 | F | Caucasian | Congenital glaucoma, aphakia, prior retinal detachment | CF 2' | BLP | |
| Yoga | 54 | M | African American | Diabetic Retinopathy | LP | LP | |
| Yoga | 65 | M | African American | Childhood accident, firecracker | BLP | BLP | |
| Yoga | 85 | F | Caucasian | AMD | CF @ 3' | HM | |
| Yoga | 38 | F | Caucasian | Congenital cataracts, aphakia with band keratopathy, phthisis OD | CF @ 1' | NLP | |
| Yoga | 62 | F | Caucasian | Retinopathy of Prematurity | NLP | BLP | |
| Yoga | 27 | F | African American | Stargardt's Disease | 20/320 | 20/320 | |
| Yoga | 58 | F | Caucasian | Retinitis Pigmentosa | 20/70 | 20/70 | <10 |
| Waitlist | 60 | F | Caucasian | Retinitis Pigmentosa | CF | HM | <10 |
| Waitlist | 64 | F | African American | Stargardt's Maculopathy | 20/320 | 20/320 | |
| Waitlist | 60 | M | Caucasian | Retinitis Pigmentosa | BLP | BLP | |
| Waitlist | 60 | F | Caucasian | Nystagmus, Congenital Cataracts, Band Keratopathy | HM | NLP | |
| Waitlist | 33 | F | Hispanic | Optic Nerve Damage | LP | LP | |
| Waitlist | 49 | M | Caucasian | Stargardt's Disease | 20/300 | 20/300 | |
| Waitlist | 56 | M | Caucasian | Ischemic Optic Neuropathy | LP | LP | |
| Waitlist | 59 | F | Caucasian | End-stage Glaucoma | LP | LP |
OS, Left Eye; OD, Right Eye; CF, Counting Fingers; HM, Hand Motion; LP, Light Perception; BLP, Bare Light Perception; NLP, No Light Perception
Primary Outcomes—Absolute COP MTV (mm/s) and Relative Stability Indices.
| Group Mean(SD) | ||||||
|---|---|---|---|---|---|---|
| Group | Outcome | Baseline | Post | 95% CI of the Mean Difference | P-value | Effect Size (η2) |
|
| FirmEO | 11.91 (3.14) | 12.02 (2.21) | -0.10 (-2.39 2.18) | 0.92 | 0.00 |
| FirmEC | 12.65 (2.62) | 13.04 (2.50) | -0.39 (-2.35 1.58) | 0.66 | 0.03 | |
| FoamEO | 22.62 (6.12) | 29.03 (7.49) | -6.41 (-10.45–2.37) | 0.01 | 0.63 | |
| FoamEC | 22.90 (3.19) | 33.09 (10.03) | -10.19 (-16.22–4.16) | 0.01 | 0.66 | |
|
| FirmEO | 14.07 (5.01) | 14.28 (4.38) | -0.21 (-2.26 1.84) | 0.82 | 0.01 |
| FirmEC | 13.49 (4.93) | 14.49 (4.14) | -1.00 (-2.86 0.86) | 0.24 | 0.19 | |
| FoamEO | 23.82 (8.25) | 25.83 (6.70) | -2.00 (-6.82 2.80) | 0.36 | 0.12 | |
| FoamEC | 27.80 (7.30) | 31.08 (8.29) | -3.29 (-8.98 2.40) | 0.21 | 0.21 | |
|
| SIFirm | 0.02 (0.08) | 0.03 (0.04) | -0.01 (-0.07 0.06) | 0.82 | 0.01 |
| SIFoam | 0.01 (0.08) | 0.03 (0.04) | -0.02 (-0.07 0.03) | 0.34 | 0.11 | |
| SIEO | 0.19 (0.06) | 0.24 (0.07) | -0.05 (-0.10–0.01) | 0.04 | 0.42 | |
| SIEC | 0.18 (0.07) | 0.25 (0.05) | -0.07 (-0.11–0.03) | 0.01 | 0.66 | |
| SIV | 0.20 (0.08) | 0.26 (0.06) | -0.07 (-0.13–0.01) | 0.04 | 0.43 | |
|
| SIFirm | -0.02 (0.03) | 0.01 (0.05) | -0.02 (-0.06 0.02) | 0.24 | 0.19 |
| SIFoam | 0.05 (0.08) | 0.05 (0.05) | 0.00 (-0.08 0.08) | 1.00 | 0.00 | |
| SIEO | 0.16 (0.03) | 0.17 (0.08) | -0.16 (-0.08 0.05) | 0.58 | 0.05 | |
| SIEC | 0.21 (0.06) | 0.21 (0.06) | 0.01 (-0.07 0.07) | 0.97 | 0.00 | |
| SIV | 0.20 (0.06) | 0.22 (0.06) | -0.02 (-0.08 0.04) | 0.48 | 0.07 | |
Primary outcomes are analyzed by paired samples t-tests. 95% CI are confidence intervals for the mean difference pre-post t-tests. Effect sizes for primary outcomes were calculated as the partial eta squared, η2 = t2/(t2 + (N-1)). We use the Ferguson (2009) effect size criteria for η2: small = 0.2, moderate = 0.5, large = 0.8. SI = Stability Index, EO = Eyes Open, EC = Eyes Closed, V = Vestibular,
* = Statistically significant.
Secondary Outcomes.
| Median (IQR) | |||||
|---|---|---|---|---|---|
| Group | Outcomes | Baseline | Post | P-value | Effect Size ( |
|
| OLS-EO (s) | 4.46 (12.94) | 6.87 (26.25) | 0.04 | 0.49 |
| Chair Sit & Reach (in) | 0.00 (4.00) | 1.50 (4.25) | 0.01 | 0.60 | |
| 30s Chair Stand (s) | 13.00 (4.50) | 14.00 (5.50) | 0.05 | 0.47 | |
|
| OLS-EO (s) | 4.93 (7.04) | 7.15 (6.45) | 0.31 | 0.25 |
| Chair Sit & Reach (in) | -2.5 (8.5) | -3.25 (7.63) | 0.75 | 0.08 | |
| 30s Chair Stand (s) | 13.00 (4.50) | 11.50 (6) | 0.31 | 0.26 | |
Secondary outcomes were calculated using the Wilcoxon Signed Rank test and effect sizes were calculated as r = z/√N, where N is the number of observations over the two time points. Ferguson's (2009) effect size for r is the following criteria: small = 0.04, moderate = 0.25, large = 0.64. IQR = Interquartile Range, (in) = Inches, (s) Seconds,
* = Significant Effect, OLS = One-Legged Stand, EO = Eyes Open.
Fig 3Visually impaired students performing tree pose.